Alphabet is the mother company of Google. Google’s (GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug. Calico’s fosigotifator was tested for amyotrophic lateral sclerosis (ALS),

Age is an issue of mind over matter — h/t Mark Twain — but early ALS clinical trial results from Google-backed aging-disease drug maker Calico do matter.

The company said Monday that fosigotifator failed to outperform placebo in slowing the neurogenerative disease, but is testing it further and for other conditions.